Multiple myxoid cellular neurothekeomas in a patient with systemic lupus erythematosus.


Journal

Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124

Informations de publication

Date de publication:
Jul 2021
Historique:
revised: 24 03 2021
received: 11 01 2021
accepted: 06 04 2021
pubmed: 13 4 2021
medline: 27 11 2021
entrez: 12 4 2021
Statut: ppublish

Résumé

Cellular neurothekeoma is a cutaneous tumor with a distinctive histopathologic appearance characterized by a dermal-based multinodular proliferation of epithelioid to spindled cells. Although the tumor may show varying amounts of myxoid stroma, extensive myxoid change is uncommon. The tumor typically presents as a solitary nodule with a predilection for the head and neck and upper limbs; examples of multiple cellular neurothekeomas are decidedly rare. The present report describes a unique case of multiple myxoid cellular neurothekeomas arising in a 60-year-old female with systemic lupus erythematosus. Two papular lesions were identified involving the skin inferior to the umbilicus and the left inguinal crease. Both lesions were histopathologically similar, forming a nodular mass composed of epithelioid cells in a prominent myxoid stroma. By immunohistochemistry the lesional cells expressed NKI/C3, microphthalmia transcription factor (MiTF), and CD68, with focal staining for PGP9.5, factor XIIIa, and CD10 also observed. The tumors were negative for S-100, SOX-10, epithelial membrane antigen, desmin, smooth muscle actin, glial fibrillary acid protein, and CD34. The present case confirms that cellular neurothekeoma can present clinically as multiple lesions and can have a predominantly myxoid appearance, potentially mimicking other cutaneous myxoid lesions.

Identifiants

pubmed: 33844324
doi: 10.1111/cup.14025
doi:

Substances chimiques

Antigens, CD 0
Antigens, Differentiation, Myelomonocytic 0
Biomarkers, Tumor 0
CD68 antigen, human 0
MITF protein, human 0
Microphthalmia-Associated Transcription Factor 0
UCHL1 protein, human 0
Factor XIIIa EC 2.3.2.13
Ubiquitin Thiolesterase EC 3.4.19.12
Neprilysin EC 3.4.24.11

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

980-985

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Hornick JL, Fletcher CD. Cellular neurothekeoma: detailed characterization in a series of 133 cases. Am J Surg Pathol. 2007;31(3):329-340.
Fetsch JF, Laskin WB, Hallman JR, Lupton GP, Miettinen M. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information. Am J Surg Pathol. 2007;31(7):1103-1114.
Stratton J, Billings SD. Cellular neurothekeoma: analysis of 37 cases emphasizing atypical histologic features. Mod Pathol. 2014;27(5):701-710.
Yang YW, Shih IH, Huang YH, Kuo TT, Hong HS. Mixed-type neurothekeoma presenting with an unusual clinical appearance of multiple satellite lesions on the back. Dermatol Surg. 2005;31(6):720-722.
Mahalingam M, Alter JN, Bhawan J. Multiple cellular neurothekeomas-a case report and review on the role of immunohistochemistry as a histologic adjunct. J Cutan Pathol. 2006;33(1):51-56.
García-Gutiérrez M, Toussaint-Caire S, González-Sánchez P, Ortiz-Hidalgo C. Multiple desmoplastic cellular neurothekeomas localized to the face of a 16-year-old boy. Am J Dermatopathol. 2010;32(5):509-513.
Hernández-Martín A, Colmenero I, Torrelo A. Cellular neurothekeomas arising on a café-au-lait macule. Pediatr Dermatol. 2011;28(1):77-79.
Li J, Shi Z, Jing J. Neurothekeomas of the thoracic and lumbar area in an adult man: a case report. Mol Clin Oncol. 2014;2(1):156-158.
Kelly J, Kristijansson A, Dadras S, Chang MW. Multiple, familial, cellular neurothekeomas mimicking molluscum contagiosum. J Am Acad Dermatol. 2015;72(5):AB201.
Almeida TFA, Verli FD, Dos Santos CRR, et al. Multiple desmoplastic cellular neurothekeomas in child: report of the first oral case and review of the literature. Head Neck Pathol. 2018;12(1):75-81.
Gill P, Abi Daoud MS. Multiple cellular neurothekeomas in a middle-aged woman including the lower extremity: a case report and review of the current literature. J Cutan Pathol. 2019;46(1):67-73.
Myers DJ, Collins RA, Krauland KJ. Neurothekeoma multiplicity-a multiply occurring and recurrent case of a rare entity. Am J Dermatopathol. 2019;41(10):e126.
Choi S, Cho SI, Lee C, Kwak Y, Mun JH. Dermoscopy of multiple cellular neurothekeoma: an analysis of 11 neurothekeomas in a middle-aged woman. Australas J Dermatol. 2020;61(1):e73-e76.
Wang AR, May D, Bourne P, Scott G. PGP9.5: a marker for cellular neurothekeoma. Am J Surg Pathol. 1999;23(11):1401-1407.
Page RN, King R, Mihm MC Jr, Googe PB. Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma. Mod Pathol. 2004;17(2):230-234.
Fetsch JF, Laskin WB, Miettinen M. Nerve sheath myxoma: a clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate. Am J Surg Pathol. 2005;29(12):1615-1624.
Calonje E, Guerin D, McCormick D, Fletcher CD. Superficial angiomyxoma: clinicopathologic analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence. Am J Surg Pathol. 1999;23(8):910-917.
Zelger BG, Calonje E, Zelger B. Myxoid dermatofibroma. Histopathology. 1999;34(4):357-364.
Lin RY, Landsman L, Krey PR, Lambert WC. Multiple dermatofibromas and systemic lupus erythematosus. Cutis. 1986;37(1):45-47, 49.
Fujisawa T, Seishima M. Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren's syndrome. Mod Rheumatol. 2010;20(4):396-400.
Niiyama S, Katsuoka K, Happle R, Hoffmann R. Multiple eruptive dermatofibromas: a review of the literature. Acta Derm Venereol. 2002;82(4):241-244.
Sheth S, Li X, Binder S, Dry SM. Differential gene expression profiles of neurothekeomas and nerve sheath myxomas by microarray analysis. Mod Pathol. 2011;24(3):343-354.

Auteurs

Sean K Lau (SK)

Southern California Permanente Medical Group, Department of Pathology, Orange County-Anaheim Medical Center, Anaheim, California, USA.

David S Cassarino (DS)

Southern California Permanente Medical Group, Department of Pathology, Los Angeles Medical Center, Los Angeles, California, USA.

Stephen S Koh (SS)

Southern California Permanente Medical Group, Department of Pathology, Orange County-Anaheim Medical Center, Anaheim, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH